Skip to content
  • Tuesday, 27 October 2026
  • 9:14 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Unveils Post-Wegovy Growth Roadmap as Shares Slide Despite Ambitious 2030 Targets
Pharmaceutical R&D

Novo Unveils Post-Wegovy Growth Roadmap as Shares Slide Despite Ambitious 2030 Targets

Teuku Ryan Sep 22, 2026 0

The pharmaceutical landscape is undergoing a profound transformation, and Danish drugmaking giant Novo is aggressively positioning itself for a future…

Read More
Pharmaceutical R&D

Novo Partners with Anthropic to Harness Claude AI in Ambitious R&D Overhaul

Teuku Ryan Sep 17, 2026 0

Pharmaceutical giant Novo has announced a strategic partnership with artificial intelligence pioneer Anthropic, leveraging the tech company’s advanced AI assistant,…

Read More
Data Science & Bioinformatics

Humanity’s Last Exam: Unpacking the Ambitious AI Benchmark Sparking Debate on General Intelligence and Safety

Evan Lee Salim Jul 2, 2026 0

Humanity’s Last Exam (HLE) has emerged as a formidable new benchmark designed to rigorously assess the advanced reasoning and deep…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce Competition

Teuku Ryan May 8, 2026 0

Novo Nordisk’s groundbreaking oral semaglutide medication, branded as Wegovy, has emerged as a powerful financial engine, propelling the Danish pharmaceutical…

Read More
Laboratory Automation & Robotics

Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance

Lana Keisha Mar 30, 2026 0

In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…

Read More
The BioTechniques Image Competition 2026 Reveals Its Finalists Following Unprecedented Global Submissions and A Three-Way Tie For Tenth PlaceEClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformScientists Harness Synthetic Rotation to Validate Decades-Old Theories of Black Hole Energy Extraction and Wave AmplificationBioMarin Pharmaceutical and Profluent Partner to Accelerate AI-Driven Enzyme Therapies in Landmark Drug Discovery Collaboration
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ